1. Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases

   • Monika Martiniakova
   • Roman Biro
   • Radoslav Omelka

   Review Open access 16 February 2024 Pages: 435 - 452

   

2. Systemic and local effect of oxidative stress on recurrent aphthous stomatitis: systematic review

   • Cristina Estornut
   • Giulia Rinaldi
   • Martín Pérez-Leal

   Review 20 February 2024 Pages: 453 - 463

   

3. Emerging therapeutic targets in systemic sclerosis

   • Steven O’Reilly

   Review 22 February 2024 Pages: 465 - 478

4. Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer

   • Rafaela Nasser Veiga
   • Alexandre Luiz Korte de Azevedo
   • Daniela Fiori Gradia

   Review 23 February 2024 Pages: 479 - 493

   

5. The role of regulated necrosis in diabetes and its complications

   • Haipeng Pang
   • Gan Huang
   • Zhiguang Zhou

   Review 23 February 2024 Pages: 495 - 505

   

6. FDA-approved disulfiram as a novel treatment for aggressive leukemia

   • Mawar Karsa
   • Lin Xiao
   • Klaartje Somers

   Original Article Open access 13 February 2024 Pages: 507 - 519

   

7. Novel high-yield potato protease inhibitor panels block a wide array of proteases involved in viral infection and crucial tissue damage

   • Nienke Visser
   • Laure C. M. Herreman
   • Jon D. Laman

   Original Article Open access 21 February 2024 Pages: 521 - 536

   

8. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease

   • Umm E. Habiba
   • Nasar Khan
   • Amna Umer

   Original Article Open access 29 February 2024 Pages: 537 - 570

   

9. The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitis

   • Ji-Hyun Lee
   • Seung Hoon Lee
   • Chang-Nam Son

   Original Article 29 February 2024 Pages: 571 - 583